Or is it not appropriate or time yet
Last line from his yesterday abstract.
"Observations of increases in PD-L1 on CTCs and/or CAMLs are hypothesis-generating and support investigation of immune checkpoint inhibitor strategies for patients who progress".
Did you watch this already?
https://www.vumedi.com/video/sabcs-2025-panel...-in-mtnbc/